十一月 2025
- Home
- TFS Trial Form Support
十一月 2025的TFS Trial Form Support市场份额分析
Explore how natural history studies, external controls, and real-world evidence are transforming rare neurological disease trials.
TFS Trial Form Support(包含公司地区分支机构)
查看更多网站流量和参与度信息- tfscro.com
TFS Trial Form Support收入截至 十一月 2025为 200M - 500M
TFS Trial Form Support主要域名产生的收入
3 年中TFS Trial Form Support主要域名的收入
TFS Trial Form Support主要域名的收入
TFS Trial Form Support热门域名的总访问量
了解TFS Trial Form Support市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
TFS Trial Form Support热门域名的平均访问时长
分析TFS Trial Form Support参与度指标。
过去 3 个月的平均访问时长
子公司明细
TFS Trial Form Support热门域名的平均页面浏览量
了解TFS Trial Form Support如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
TFS Trial Form Support 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻TFS International AB hires Miriam Martin as Vice President of Business Development, Clinical Development Services.TFS HealthScience appoints Miriam Martin as Vice President of Business Development, Clinical Development Services.
三月 25, 2025阅读更多
新闻TFS International AB hired Markus Granlund as CEO on Feb 24th '25.LUND, S.E., February 24, 2025 - TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce the appointment of Katarina Ageborg as Chairman of the Board and Markus Granlund as acting CEO, effective immediately.
二月 24, 2025阅读更多
新闻TFS International AB hired Katarina Ageborg as CEO on Feb 24th '25.LUND, Sweden, Feb. 24, 2025 /PRNewswire/ - TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce the appointment of Katarina Ageborg as Chairman of the Board and Markus Granlund as acting CEO, effective immediately.
二月 24, 2025阅读更多
查看 TFS Trial Form Support 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。